SYRE – spyre therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trial of SPY001, its Novel Half-life Extended anti-a4ß7 Antibody, for the Treatment of Inflammatory Bowel Disease [Yahoo! Finance]
Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trial of SPY001, its Novel Half-life Extended anti-a4ß7 Antibody, for the Treatment of Inflammatory Bowel Disease
Spyre Therapeutics Announces Grants of Inducement Awards
Spyre Therapeutics to Participate in the Jefferies Global Healthcare Conference [Yahoo! Finance]
Spyre Therapeutics to Participate in the Jefferies Global Healthcare Conference
Form SC 13G/A Spyre Therapeutics, Inc. Filed by: FMR LLC
Form 8-K Spyre Therapeutics, Inc. For: May 30
Form 4 Spyre Therapeutics, Inc. For: May 14 Filed by: Kiselak Tomas
Form 4 Spyre Therapeutics, Inc. For: May 14 Filed by: Albers Jeffrey W.
Form 4 Spyre Therapeutics, Inc. For: May 14 Filed by: Milligan Sandra
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.